Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioembolization Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Transarterial Radioembolization (TARE)
1.2.3 Selective Internal Radiation Therapy (SIRT)
1.3 Market by Application
1.3.1 Global Radioembolization Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioembolization Cancer Treatment Market Perspective (2018-2033)
2.2 Radioembolization Cancer Treatment Growth Trends by Region
2.2.1 Global Radioembolization Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Radioembolization Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Radioembolization Cancer Treatment Forecasted Market Size by Region (2024-2033)
2.3 Radioembolization Cancer Treatment Market Dynamics
2.3.1 Radioembolization Cancer Treatment Industry Trends
2.3.2 Radioembolization Cancer Treatment Market Drivers
2.3.3 Radioembolization Cancer Treatment Market Challenges
2.3.4 Radioembolization Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioembolization Cancer Treatment Players by Revenue
3.1.1 Global Top Radioembolization Cancer Treatment Players by Revenue (2018-2023)
3.1.2 Global Radioembolization Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Radioembolization Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioembolization Cancer Treatment Revenue
3.4 Global Radioembolization Cancer Treatment Market Concentration Ratio
3.4.1 Global Radioembolization Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioembolization Cancer Treatment Revenue in 2022
3.5 Radioembolization Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Radioembolization Cancer Treatment Product Solution and Service
3.7 Date of Enter into Radioembolization Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioembolization Cancer Treatment Breakdown Data by Type
4.1 Global Radioembolization Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Type (2024-2033)
5 Radioembolization Cancer Treatment Breakdown Data by Application
5.1 Global Radioembolization Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Radioembolization Cancer Treatment Market Size (2018-2033)
6.2 North America Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Radioembolization Cancer Treatment Market Size by Country (2018-2023)
6.4 North America Radioembolization Cancer Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioembolization Cancer Treatment Market Size (2018-2033)
7.2 Europe Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Radioembolization Cancer Treatment Market Size by Country (2018-2023)
7.4 Europe Radioembolization Cancer Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioembolization Cancer Treatment Market Size (2018-2033)
8.2 Asia-Pacific Radioembolization Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioembolization Cancer Treatment Market Size (2018-2033)
9.2 Latin America Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Radioembolization Cancer Treatment Market Size by Country (2018-2023)
9.4 Latin America Radioembolization Cancer Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioembolization Cancer Treatment Market Size (2018-2033)
10.2 Middle East & Africa Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Terumo Corporation
11.1.1 Terumo Corporation Company Detail
11.1.2 Terumo Corporation Business Overview
11.1.3 Terumo Corporation Radioembolization Cancer Treatment Introduction
11.1.4 Terumo Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.1.5 Terumo Corporation Recent Development
11.2 Merit Medical Systems
11.2.1 Merit Medical Systems Company Detail
11.2.2 Merit Medical Systems Business Overview
11.2.3 Merit Medical Systems Radioembolization Cancer Treatment Introduction
11.2.4 Merit Medical Systems Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.2.5 Merit Medical Systems Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Detail
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Radioembolization Cancer Treatment Introduction
11.3.4 Cook Medical Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.3.5 Cook Medical Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Detail
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Radioembolization Cancer Treatment Introduction
11.4.4 Boston Scientific Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Radioembolization Cancer Treatment Introduction
11.5.4 Medtronic Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.5.5 Medtronic Recent Development
11.6 Stryker Corporation
11.6.1 Stryker Corporation Company Detail
11.6.2 Stryker Corporation Business Overview
11.6.3 Stryker Corporation Radioembolization Cancer Treatment Introduction
11.6.4 Stryker Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.6.5 Stryker Corporation Recent Development
11.7 Depuy Synthes (J&J)
11.7.1 Depuy Synthes (J&J) Company Detail
11.7.2 Depuy Synthes (J&J) Business Overview
11.7.3 Depuy Synthes (J&J) Radioembolization Cancer Treatment Introduction
11.7.4 Depuy Synthes (J&J) Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.7.5 Depuy Synthes (J&J) Recent Development
11.8 BTG International Limited
11.8.1 BTG International Limited Company Detail
11.8.2 BTG International Limited Business Overview
11.8.3 BTG International Limited Radioembolization Cancer Treatment Introduction
11.8.4 BTG International Limited Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.8.5 BTG International Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radioembolization Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Transarterial Radioembolization (TARE)
Table 3. Key Players of Selective Internal Radiation Therapy (SIRT)
Table 4. Global Radioembolization Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Radioembolization Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Radioembolization Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Radioembolization Cancer Treatment Market Share by Region (2018-2023)
Table 8. Global Radioembolization Cancer Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Radioembolization Cancer Treatment Market Share by Region (2024-2033)
Table 10. Radioembolization Cancer Treatment Market Trends
Table 11. Radioembolization Cancer Treatment Market Drivers
Table 12. Radioembolization Cancer Treatment Market Challenges
Table 13. Radioembolization Cancer Treatment Market Restraints
Table 14. Global Radioembolization Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Radioembolization Cancer Treatment Market Share by Players (2018-2023)
Table 16. Global Top Radioembolization Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioembolization Cancer Treatment as of 2022)
Table 17. Ranking of Global Top Radioembolization Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Radioembolization Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Radioembolization Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Radioembolization Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radioembolization Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Radioembolization Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Radioembolization Cancer Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Radioembolization Cancer Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Radioembolization Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Radioembolization Cancer Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Radioembolization Cancer Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Radioembolization Cancer Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Radioembolization Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Radioembolization Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Radioembolization Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Radioembolization Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Radioembolization Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Radioembolization Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Radioembolization Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Terumo Corporation Company Detail
Table 47. Terumo Corporation Business Overview
Table 48. Terumo Corporation Radioembolization Cancer Treatment Product
Table 49. Terumo Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 50. Terumo Corporation Recent Development
Table 51. Merit Medical Systems Company Detail
Table 52. Merit Medical Systems Business Overview
Table 53. Merit Medical Systems Radioembolization Cancer Treatment Product
Table 54. Merit Medical Systems Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 55. Merit Medical Systems Recent Development
Table 56. Cook Medical Company Detail
Table 57. Cook Medical Business Overview
Table 58. Cook Medical Radioembolization Cancer Treatment Product
Table 59. Cook Medical Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 60. Cook Medical Recent Development
Table 61. Boston Scientific Corporation Company Detail
Table 62. Boston Scientific Corporation Business Overview
Table 63. Boston Scientific Corporation Radioembolization Cancer Treatment Product
Table 64. Boston Scientific Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 65. Boston Scientific Corporation Recent Development
Table 66. Medtronic Company Detail
Table 67. Medtronic Business Overview
Table 68. Medtronic Radioembolization Cancer Treatment Product
Table 69. Medtronic Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 70. Medtronic Recent Development
Table 71. Stryker Corporation Company Detail
Table 72. Stryker Corporation Business Overview
Table 73. Stryker Corporation Radioembolization Cancer Treatment Product
Table 74. Stryker Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 75. Stryker Corporation Recent Development
Table 76. Depuy Synthes (J&J) Company Detail
Table 77. Depuy Synthes (J&J) Business Overview
Table 78. Depuy Synthes (J&J) Radioembolization Cancer Treatment Product
Table 79. Depuy Synthes (J&J) Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 80. Depuy Synthes (J&J) Recent Development
Table 81. BTG International Limited Company Detail
Table 82. BTG International Limited Business Overview
Table 83. BTG International Limited Radioembolization Cancer Treatment Product
Table 84. BTG International Limited Revenue in Radioembolization Cancer Treatment Business (2018-2023) & (US$ Million)
Table 85. BTG International Limited Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioembolization Cancer Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Radioembolization Cancer Treatment Market Share by Type: 2022 VS 2033
Figure 3. Transarterial Radioembolization (TARE) Features
Figure 4. Selective Internal Radiation Therapy (SIRT) Features
Figure 5. Global Radioembolization Cancer Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Radioembolization Cancer Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Radioembolization Cancer Treatment Report Years Considered
Figure 11. Global Radioembolization Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Radioembolization Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Radioembolization Cancer Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Radioembolization Cancer Treatment Market Share by Players in 2022
Figure 15. Global Top Radioembolization Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioembolization Cancer Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Radioembolization Cancer Treatment Revenue in 2022
Figure 17. North America Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Radioembolization Cancer Treatment Market Share by Country (2018-2033)
Figure 19. United States Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Radioembolization Cancer Treatment Market Share by Country (2018-2033)
Figure 23. Germany Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Radioembolization Cancer Treatment Market Share by Region (2018-2033)
Figure 31. China Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Radioembolization Cancer Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Radioembolization Cancer Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Radioembolization Cancer Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Terumo Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 46. Merit Medical Systems Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 47. Cook Medical Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 48. Boston Scientific Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 49. Medtronic Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 50. Stryker Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 51. Depuy Synthes (J&J) Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 52. BTG International Limited Revenue Growth Rate in Radioembolization Cancer Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed